Modified FOLFIRINOX for unresectable locally advanced/metastatic pancreatic cancer. A real-world comparison of an attenuated with a full dose in a single center experience

Modified FOLFIRINOX for unresectable locally advanced/metastatic pancreatic cancer. A real-world comparison of an attenuated with a full dose in a single center experience

Luigi Cavanna,1 Elisa Maria Stroppa,1 Chiara Citterio,1 Patrizia Mordenti,1 Camilla Di Nunzio,1 Silvia Peveri,2 Elena Orlandi,1 Stefano Vecchia31Oncology and Hematology Department, Oncology Unit, Piacenza General Hospital, Piacenza, Italy; 2Allergology and Statistics Unit, Piacenza General Hospital,...

Full description

Bibliographic Details
Main Authors: Cavanna L, Stroppa EM, Citterio C, Mordenti P, Di Nunzio C, Peveri S, Orlandi E, Vecchia S
Format: Article
Language:English
Published: Dove Medical Press 2019-04-01
Series:OncoTargets and Therapy
Subjects:
Metastatic pancreatic cancer
locally advanced pancreatic cancer
FOLFIRINOX
chemotherapy
Online Access:https://www.dovepress.com/modified-folfirinox-for-unresectable-locally-advancedmetastatic-pancre-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/modified-folfirinox-for-unresectable-locally-advancedmetastatic-pancre-peer-reviewed-article-OTT

Similar Items